{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:49:29Z","timestamp":1790268569108,"version":"4.1.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,2,1]]},"DOI":"10.1097\/qai.0b013e31823d8693","type":"journal-article","created":{"date-parts":[[2012,1,6]],"date-time":"2012-01-06T09:19:42Z","timestamp":1325841582000},"page":"185-193","source":"Crossref","is-referenced-by-count":105,"title":["Identifying At-Risk Populations in Kenya and South Africa"],"prefix":"10.1097","volume":"59","author":[{"given":"Matthew A.","family":"Price","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasima","family":"Rida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Mwangome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaudensia","family":"Mutua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keren","family":"Middelkoop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surita","family":"Roux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haile S.","family":"Okuku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda-Gail","family":"Bekker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omu","family":"Anzala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Ngugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwynn","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paramesh","family":"Chetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauli N.","family":"Amornkul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard J.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-14-20210131","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1586\/14760584.5.2.167","article-title":"AIDS vaccine efficacy trials: expand capacity and prioritize. Throughout Africa, Asia and Latin America state-of-the-art clinics and laboratories exist where, 4 years ago, there were none.","volume":"5","author":"Excler","year":"2006","journal-title":"Expert Rev Vaccines"},{"issue":"suppl 4","key":"R3-14-20210131","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1097\/01.aids.0000390707.58512.5e","article-title":"HIV vaccines: current status worldwide and in Africa.","volume":"24","author":"Fast","year":"2010","journal-title":"AIDS"},{"key":"R4-14-20210131","doi-asserted-by":"crossref","first-page":"e298","DOI":"10.1371\/journal.pmed.0020298","article-title":". Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial.","volume":"2","author":"Auvert","year":"2005","journal-title":"PLoS Med"},{"key":"R5-14-20210131","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0140-6736(07)60312-2","article-title":". Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial.","volume":"369","author":"Bailey","year":"2007","journal-title":"Lancet"},{"key":"R6-14-20210131","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(07)60313-4","article-title":". Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial.","volume":"369","author":"Gray","year":"2007","journal-title":"Lancet"},{"key":"R7-14-20210131","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/QAI.0b013e31815c71f7","article-title":". The value of site preparedness studies for future implementation of phase 2IIbIII HIV prevention trials: experience from the HPTN 055 study.","volume":"47","author":"Ramjee","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R8-14-20210131","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.1193748","article-title":". Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.","volume":"329","author":"Abdool Karim","year":"2010","journal-title":"Science"},{"key":"R9-14-20210131","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa1105243","article-title":". Prevention of HIV-1 infection with early antiretroviral therapy.","volume":"365","author":"Cohen","year":"2011","journal-title":"N Engl J Med"},{"key":"R10-14-20210131","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1016\/j.vaccine.2008.02.071","article-title":". Safety and immunogenicity of recombinant low-dosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa.","volume":"26","author":"Jaoko","year":"2008","journal-title":"Vaccine"},{"key":"R11-14-20210131","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/S0264-410X(02)00064-6","article-title":"HIV vaccines: the Uganda experience.","volume":"20","author":"Mugyenyi","year":"2002","journal-title":"Vaccine"},{"key":"R12-14-20210131","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1728-4465.2006.00091.x","article-title":"Challenges in microbicide trial design and implementation.","volume":"37","author":"van de Wijgert","year":"2006","journal-title":"Stud Fam Plann"},{"issue":"suppl 2","key":"R13-14-20210131","first-page":"S277","article-title":"Behavioral research contributions to planning and conducting HIV vaccine efficacy studies.","volume":"10","author":"Temoshok","year":"1994","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R14-14-20210131","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1097\/QAD.0b013e3282eee70c","article-title":". A strategy for accelerating the development of preventive AIDS vaccines.","volume":"21","author":"Excler","year":"2007","journal-title":"AIDS"},{"key":"R15-14-20210131","first-page":"669","article-title":"Priddy F, et al..","volume":"27","author":"Excler","year":"2011","journal-title":"AIDS vaccines and preexposure prophylaxis: is synergy possible AIDS Res Hum Retroviruses"},{"key":"R16-14-20210131","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1126\/science.1206399","article-title":". AIDS. Turning the tide against HIV.","volume":"333","author":"Shattock","year":"2011","journal-title":"Science"},{"key":"R18-14-20210131","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":". Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.","volume":"363","author":"Grant","year":"2010","journal-title":"N Engl J Med"},{"key":"R19-14-20210131","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/QAD.0b013e328337798a","article-title":". Weighing the gold in the gold standard: challenges in HIV prevention research.","volume":"24","author":"Padian","year":"2010","journal-title":"AIDS"},{"issue":"suppl 4","key":"R20-14-20210131","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1097\/01.aids.0000390710.04255.2b","article-title":". HIV prevention research: taking stock and the way forward.","volume":"24","author":"Hayes","year":"2010","journal-title":"AIDS"},{"key":"R21-14-20210131","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/S0140-6736(08)61547-0","article-title":". Source of new infections in generalised HIV epidemicsauthors reply (invited correspondence).","volume":"372","author":"Dunkle","year":"2008","journal-title":"Lancet"},{"key":"R24-14-20210131","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jadohealth.2007.11.144","article-title":". Adolescent and adult participation in an HIV vaccine trial preparedness cohort in South Africa.","volume":"43","author":"Middelkoop","year":"2008","journal-title":"J Adolesc Health"},{"key":"R25-14-20210131","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1473-3099(11)70098-6","article-title":". Safety and efficacy of the HVTN 503Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study.","volume":"11","author":"Gray","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"R26-14-20210131","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/QAD.0b013e3282f27035","article-title":". Reduced rates of HIV acquisition during unprotected sex by Kenyan female sex workers predating population declines in HIV prevalence.","volume":"22","author":"Kimani","year":"2008","journal-title":"AIDS"},{"key":"R28-14-20210131","doi-asserted-by":"crossref","first-page":"e1954","DOI":"10.1371\/journal.pone.0001954","article-title":". Establishing a cohort at high risk of HIV infection in South Africa: challenges and experiences of the CAPRISA 002 acute infection study.","volume":"3","author":"van Loggerenberg","year":"2008","journal-title":"PLoS One"},{"key":"R29-14-20210131","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2217\/14622416.8.4.409","article-title":". Recent HIV-1 infection in a high-risk Ugandan cohort: implications for Phase IIB test-of-concept HIV vaccine trials.","volume":"8","author":"Kebba","year":"2007","journal-title":"Pharmacogenomics"},{"key":"R30-14-20210131","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/00126334-200008150-00011","article-title":"Jr, et al.. Trends in HIV-1 incidence in a cohort of prostitutes in Kenya: implications for HIV-1 vaccine efficacy trials.","volume":"24","author":"Baeten","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R31-14-20210131","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/QAI.0b013e31817236ab","article-title":". The HVTN protocol 903 vaccine preparedness study: lessons learned in preparation for HIV vaccine efficacy trials.","volume":"48","author":"Djomand","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R33-14-20210131","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1097\/QAD.0b013e328017f843","article-title":". Are you on the market: a capture-recapture enumeration of men who sell sex to men in and around Mombasa, Kenya.","volume":"21","author":"Geibel","year":"2007","journal-title":"AIDS"},{"key":"R35-14-20210131","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1097\/QAD.0b013e3282f2704a","article-title":". HIV-1 infection in high risk men who have sex with men in Mombasa, Kenya.","volume":"21","author":"Sanders","year":"2007","journal-title":"AIDS"},{"key":"R36-14-20210131","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S0140-6736(09)61118-1","article-title":". Men who have sex with men and HIVAIDS in sub-Saharan Africa.","volume":"374","author":"Smith","year":"2009","journal-title":"Lancet"},{"key":"R37-14-20210131","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/epirev\/mxq011","article-title":". The Expanding Epidemics of HIV Type 1 Among Men Who Have Sex With Men in Low- and Middle-Income Countries: Diversity and Consistency.","volume":"32","author":"Beyrer","year":"2010","journal-title":"Epidemiol Rev"},{"key":"R38-14-20210131","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/COH.0b013e32832c3bb3","article-title":". The global epidemic of HIV infection among men who have sex with men.","volume":"4","author":"van Griensven","year":"2009","journal-title":"Curr Opin HIV AIDS"},{"key":"R39-14-20210131","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1097\/OLQ.0b013e318170589d","article-title":". Factors associated with self-reported unprotected anal sex among male sex workers in Mombasa, Kenya.","volume":"35","author":"Geibel","year":"2008","journal-title":"Sex Transm Dis"},{"key":"R40-14-20210131","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/sti.2008.031328","article-title":"Rectal microbicides: a new focus for HIV prevention.","volume":"84","author":"McGowan","year":"2008","journal-title":"Sex Transm Infect"},{"issue":"suppl 2","key":"R43-14-20210131","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1097\/QAI.0b013e31821db944","article-title":". Expanding the Space: inclusion of most-at-risk populations in HIV prevention, treatment, and care services.","volume":"57","author":"Beyrer","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R45-14-20210131","first-page":"140","article-title":"HIV incidence in sub-Saharan Africa: a review of available data with implications for surveillance and prevention planning.","volume":"11","author":"Braunstein","year":"2009","journal-title":"AIDS Rev"},{"key":"R46-14-20210131","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1097\/00002030-200111090-00013","article-title":". HIV incidence and sexually transmitted disease prevalence associated with condom use: a population study in Rakai, Uganda.","volume":"15","author":"Ahmed","year":"2001","journal-title":"AIDS"},{"key":"R47-14-20210131","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/01.aids.0000210616.90954.47","article-title":". Decline in sexually transmitted infection prevalence and HIV incidence in female barworkers attending prevention and care services in Mbeya Region, Tanzania.","volume":"20","author":"Riedner","year":"2006","journal-title":"AIDS"},{"key":"R48-14-20210131","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/01.qai.0000226795.61957.40","article-title":". Epidemiology of HIV-1 infection in agricultural plantation residents in Kericho, Kenya: preparation for vaccine feasibility studies.","volume":"43","author":"Sateren","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R49-14-20210131","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00002030-200002180-00014","article-title":". The prevalence and incidence of HIV-1 infection and syphilis in a cohort of police officers in Dar es Salaam, Tanzania: a potential population for HIV vaccine trials.","volume":"14","author":"Bakari","year":"2000","journal-title":"AIDS"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00126334-201202010-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:27:30Z","timestamp":1786048050000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-201202010-00014"}},"subtitle":["HIV Incidence in Cohorts of Men Who Report Sex With Men, Sex Workers, and Youth"],"short-title":[],"issued":{"date-parts":[[2012,2,1]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e31823d8693","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2,1]]}}}